Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Niagen Bioscience (NAGE) over the last 15 years, with Q3 2025 value amounting to 1.32.

  • Niagen Bioscience's Asset Utilization Ratio fell 2069.85% to 1.32 in Q3 2025 from the same period last year, while for Sep 2025 it was 1.32, marking a year-over-year decrease of 2069.85%. This contributed to the annual value of 1.62 for FY2024, which is 542.59% up from last year.
  • Per Niagen Bioscience's latest filing, its Asset Utilization Ratio stood at 1.32 for Q3 2025, which was down 2069.85% from 1.35 recorded in Q2 2025.
  • Niagen Bioscience's 5-year Asset Utilization Ratio high stood at 1.66 for Q3 2024, and its period low was 1.03 during Q3 2021.
  • Over the past 5 years, Niagen Bioscience's median Asset Utilization Ratio value was 1.45 (recorded in 2022), while the average stood at 1.43.
  • As far as peak fluctuations go, Niagen Bioscience's Asset Utilization Ratio skyrocketed by 4459.08% in 2022, and later crashed by 2069.85% in 2025.
  • Niagen Bioscience's Asset Utilization Ratio (Quarter) stood at 1.14 in 2021, then increased by 26.71% to 1.45 in 2022, then increased by 6.66% to 1.54 in 2023, then grew by 3.56% to 1.6 in 2024, then decreased by 17.61% to 1.32 in 2025.
  • Its Asset Utilization Ratio was 1.32 in Q3 2025, compared to 1.35 in Q2 2025 and 1.44 in Q1 2025.